Webcast Alert: Isis Pharmaceuticals' Third Quarter 2012 Financial Results Conference Call

  Webcast Alert: Isis Pharmaceuticals' Third Quarter 2012 Financial Results
                               Conference Call

PR Newswire

CARLSBAD, Calif., Oct. 29, 2012

CARLSBAD, Calif., Oct. 29, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
(NASDAQ: ISIS) announces the following webcast:

What:     Isis Pharmaceuticals' Third Quarter 2012 Financial Results
          Conference Call
When:    Tuesday, November 6, 2012 at 11:30 a.m. ET / 8:30 a.m. PT
Where:    www.isispharm.com
How:      Live on the Internet. Simply log onto our Web site listed above.
Contacts: D. Wade Walke, Ph.D.
          Executive Director, Corporate Communications and Investor Relations
          760-603-2471
          Amy Blackley, Ph.D.
          Associate Director, Corporate Communications
          760-603-2772

If you are unable to participate during the live event, a replay of the
webcast will be available for a limited time at www.isispharm.com.

ABOUT ISIS PHARMACEUTICALS, INC.
Isis is exploiting its leadership position in antisense technology to discover
and develop novel drugs for its product pipeline and for its partners. Isis'
broad pipeline consists of 25 drugs to treat a wide variety of diseases with
an emphasis on cardiovascular, metabolic, severe and rare diseases, and
cancer. Isis' partner, Genzyme, plans to commercialize Isis' lead product,
KYNAMRO™, in the United States and Europe following regulatory approval.
Isis' patents provide strong and extensive protection for its drugs and
technology. Additional information about Isis is available at
www.isispharm.com.

SOURCE Isis Pharmaceuticals, Inc.

Website: http://www.isispharm.com
 
Press spacebar to pause and continue. Press esc to stop.